Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: Genome-wide gene-expression profiles of prostate cancers and PINs

Cancer Research

Volumn 64, Issue 17, 2004, Pages 5963-5972

  Ashida, Shingo ^a,b   Nakagawa, Hidewaki ^a   Katagiri, Toyomasa ^a   Furihata, Mutsuo ^b   Iiizumi, Megumi ^a   Anazawa, Yoshio ^a   Tsunoda, Tatsuhiko ^c   Takata, Ryo ^a,e   Kasahara, Kotaro ^b   Miki, Tsuneharu ^d   Fujioka, Tomoaki ^e   Shuin, Taro ^b   Nakamura, Yusuke ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN D; BETA2 INTEGRIN; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR; FATTY ACID SYNTHASE; LAMININ; PLASMINOGEN ACTIVATOR; SMALL INTERFERING RNA; SPERMINE SYNTHASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UROKINASE;

AMACR GENE; APOD GENE; ARTICLE; CARCINOMA IN SITU; CDKN2C GENE; CLINICAL ARTICLE; DNA MICROARRAY; EPHA4 GENE; FASN GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENOME; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ITGB2 GENE; LAMB2 GENE; LASER MICROBEAM MICRODISSECTION; MALE; NUCLEOTIDE SEQUENCE; OR51E2 GENE; PLAU GENE; POV1 GENE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CANCER OVEREXPRESSED GENE 1; PROSTATE DISEASE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RODH GENE; SMS GENE; TIMP1 GENE; UNINDEXED SEQUENCE;

CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CLUSTER ANALYSIS; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RECEPTOR, EPHA4; RNA, SMALL INTERFERING;

EID: 4344707340     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0020     Document Type: Article

References (28)

1. Gronberg H. Prostate cancer epidemiology. Lancet 2003;361:859-64.
2. Han M, Partin AW, Piantadosi S, Epstein JI, Walsh PC. Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol 2001;166:416-9.
3. Roberts SG, Blute ML, Bergstralh EJ, Slezak JM, Zincke H. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer. Mayo Clin Proc 2001;76:576-81.
4. Roberts WW, Bergstralh EJ, Blute ML, et al. Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy. Urology 2001;57:1033-7.
5. Abate-Shen C, Shen MM. Molecular genetics of prostate cancer. Gene Dev 2000; 14:2410-34.
6. Di Cristofano A, De Acetis M, Koff A, Cordon-Cardo C, Pandolfi PP. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet 2001;27:222-4.
7. McNeal JE, Bostwick DG. Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol 1986;17:64-71.
8. DeMarzo AM, Nelson WG, Isaacs WB, Epstein JI. Pathological and molecular aspects of prostate cancer. Lancet 2003;361:955-64.
9. Sakr WA, Haas GP, Cassin BF, Pontes JE, Crissman JD. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 1993;150: 379-85.
10. Montironi R, Mazzucchelli R, Scarpelli M. Precancerous lesions and conditions of the prostate: from morphological and biological characterization to chemoprevention. Ann N Y Acad Sci 2002;963:169-84.
11. Nakamura T, Furukawa Y, Nakagawa H, et al. Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene 2004;23:2385-400.
12. Ono K, Tanaka T, Tsunoda T, et al. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Res 2000;60:5007-11.
13. Dhanasekaran SM, Barrette TR, Ghosh D, et al. Delineation of prognostic biomarkers in prostate cancer. Nature (Lond) 2001;412:822-6.
14. Magee JA, Araki T, Patil S, et al. Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res 2001;61:5692-6.
15. Stamey TA, Warrington JA, Caldwell MC, et al. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. J Urol 2001;166:2171-7.
16. Welsh JB, Sapinoso LM, Su AI, et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 2001;61:5974-8.
17. Rhodes DR, Barrette TR. Rubin MA, Ghosh D, Chinnaiyan AM. Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res 2002;62:4427-33.
18. Chen LM, Hodge GB, Guarda LA, Welch JL, Greenberg NM, Chai KX. Down-regulation of prostasin serine protease: a potential invasion suppressor in prostate cancer. Prostate 2001;48:93-103.
19. Takahashi S, Suzuki S, Inaguma S, et al. Down-regulated expression of prostasin in high-grade or hormone-refractory human prostate cancers. Prostate 2003;54: 187-93.
20. Qian J, Jenkins RB, Bostwick DG. Genetic and chromosomal alterations in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Eur Urol 1999;35:479-83.
21. Emmert-Buck MR, Vocke CD, Pozzatti RO, et al. Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res 1995;55: 2959-62.
22. Kovi J, Jackson MA, Heshmat MY. Ductal spread in prostatic carcinoma. Cancer (Phila) 1985;56:1566-73.
23. Rubin MA, Zhou M, Dhanasekaran SM, et al. α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 2002;287:1662-70.
24. Luo J, Zha S, Gage WR, et al. α-Methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res 2002;62:2220-6.
25. Xia C, Ma W, Wang F, Hua S, Liu M. Identification of a prostate-specific G-protein coupled receptor in prostate cancer. Oncogene 2001;20:5903-7.
26. Thomas T, Thomas TJ. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci 2001;58:244-58.
27. Doll JA, Stellmach VM, Bouck NP. et al. Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat Med 2003;9:774-80.
28. Kullander K, Klein R. Mechanisms and functions of Eph and ephrin signaling. Nat Rev Mol Cell Biol 2002;3:475-86.